Day in and day out, companies continue to clamor for the NVIDIA GPUs that are powering the AI revolution. Here are some of the big collaborations and partnerships that the company has announced (so ...

Eli Lilly upgraded on coverage expansion for obesity drugs Leerink Partners upgraded Eli Lilly (LLY) to Outperform from Market Perform, arguing that its recent pricing deal with the Trump ...

The latest investor updates on stocks that are trending on Wednesday.

Novo Nordisk A/S NVO reported third-quarter 2025 earnings of 70 cents per American Depositary Receipt (ADR), which missed the ...

Data center revenue, which folds in sales of AI chips, surged by 22% to $4.3 billion during the September quarter. A top-line ...

Pfizer (NYSE:PFE) stock rose 0.6% after the U.S. pharma giant clinched a $10 billion deal for obesity drug developer Metsera, ...

The Pharma Industry Is in a Bind. President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut U.S. drug prices. Nvidia stock rises after ...

Metsera falls sharply after Pfizer agrees to buy the weight-loss drug start-up in a deal that could be worth more than $10 ...

McDonald’s rose 0.9% after third-quarter adjusted earnings slightly missed analysts’ estimates. Same-store sales increased ...

US stocks rose Monday as Nvidia led tech gains, Apple delayed the iPhone Air, Pfizer acquired Metsera, and Trump unveiled a ...

Another name in the AI story reporting in the week ahead is Advanced Micro Devices (AMD), which has also hit fresh highs on ...

The major gauges have reached a holding pattern in a volatile week with investors seeking firm news on tariffs, earnings and ...